![]() |
|
|
Vol. 20, Issue 3, 1020-1029, February 1, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China
Submitted September 2, 2008;
Revised November 18, 2008;
Accepted November 21, 2008
Monitoring Editor: Kunxin Luo
Transforming growth factor (TGF)-β regulates a spectrum of cellular events, including cell proliferation, differentiation, and migration. In addition to the canonical Smad pathway, TGF-β can also activate mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K)/Akt, and small GTPases in a cell-specific manner. Here, we report that cholesterol depletion interfered with TGF-β–induced epithelial-mesenchymal transition (EMT) and cell migration. This interference is due to impaired activation of MAPK mediated by cholesterol-rich lipid rafts. Cholesterol-depleting agents specifically inhibited TGF-β–induced activation of extracellular signal-regulated kinase (ERK) and p38, but not Smad2/3 or Akt. Activation of ERK or p38 is required for both TGF-β–induced EMT and cell migration, whereas PI3K/Akt is necessary only for TGF-β–promoted cell migration but not for EMT. Although receptor heterocomplexes could be formed in both lipid raft and nonraft membrane compartments in response to TGF-β, receptor localization in lipid rafts, but not in clathrin-coated pits, is important for TGF-β–induced MAPK activation. Requirement of lipid rafts for MAPK activation was further confirmed by specific targeting of the intracellular domain of TGF-β type I receptor to different membrane locations. Together, our findings establish a novel link between cholesterol and EMT and cell migration, that is, cholesterol-rich lipid rafts are required for TGF-β–mediated MAPK activation, an event necessary for TGF-β–directed epithelial plasticity.
Address correspondence to: Ye-Guang Chen (ygchen{at}tsinghua.edu.cn)
Abbreviations used: EMT, epithelial-mesenchymal transition; F-actin, filamentous actin; ICD, intracellular domain; MAPK, mitogen-activated protein kinase; PI3K, phosphatidylinositol 3-kinase; TβR, TGF-β receptor; TGF, transforming growth factor.
This article has been cited by other articles:
![]() |
M. Y. Lee, J. M. Ryu, S. H. Lee, J. H. Park, and H. J. Han Lipid rafts play an important role for maintenance of embryonic stem cell self-renewal J. Lipid Res., August 1, 2010; 51(8): 2082 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sadej, H. Romanska, D. Kavanagh, G. Baldwin, T. Takahashi, N. Kalia, and F. Berditchevski Tetraspanin CD151 Regulates Transforming Growth Factor {beta} Signaling: Implication in Tumor Metastasis Cancer Res., July 15, 2010; 70(14): 6059 - 6070. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kahlem and S. J. Newfeld Informatics approaches to understanding TGF{beta} pathway regulation Development, November 15, 2009; 136(22): 3729 - 3740. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, Y. Jiang, Q. Wang, X. Ma, Z. Xiao, W. Zuo, X. Fang, and Y.-G. Chen Single-molecule imaging reveals transforming growth factor-{beta}-induced type II receptor dimerization PNAS, September 15, 2009; 106(37): 15679 - 15683. [Abstract] [Full Text] [PDF] |
||||